2024-04-30  8:37:13 AM Chg. +1.6600 Volume Bid9:32:22 PM Ask9:32:22 PM Market Capitalization Dividend Y. P/E Ratio
38.3200EUR +4.53% 0
Turnover: 0.0000
-Bid Size: - -Ask Size: - 11 bill.EUR - -

Business description

Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing and marketing, with a strong focus on prescription medicines.
 

Management board & Supervisory board

CEO
Haruo Naito
Management board
Yasushi Okada, Kenta Takahashi, Terushige Iike
Supervisory board
Hideyo Uchiyama, Hideki Hayashi, Yumiko Miwa, Fumihiko Ike, Yoshiteru Kato, Ryota Miura, Hiroyuki Kato, Richard Thornley, Toru Moriyama, Yuko Yasuda
 

Company data

Name: Eisai Co.,Ltd.
Address: 4-6-10, Koishikawa Bunkyo-ku,Tokyo 112-8088
Phone: + 81 3 3817 3700
Fax: -
E-mail: -
Internet: www.eisai.co.jp
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: -
End of financial year: 03-31
Free Float: -
IPO date: 1961-09-15

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: -

Company calendar

CW 27 | 2024-07-01 Dividend Payment